38 related articles for article (PubMed ID: 3003091)
21. Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis).
Gupta RS; Chopra A; Stetsko DK
J Cell Physiol; 1986 May; 127(2):197-206. PubMed ID: 3009493
[TBL] [Abstract][Full Text] [Related]
22. Active ingredients in Chinese medicines promoting blood circulation as Na+/K+ -ATPase inhibitors.
Chen RJ; Jinn TR; Chen YC; Chung TY; Yang WH; Tzen JT
Acta Pharmacol Sin; 2011 Feb; 32(2):141-51. PubMed ID: 21293466
[TBL] [Abstract][Full Text] [Related]
23. Repurposing Cardiac Glycosides: Drugs for Heart Failure Surmounting Viruses.
Škubník J; Bejček J; Pavlíčková VS; Rimpelová S
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577097
[TBL] [Abstract][Full Text] [Related]
24. Cardiac glycosides with target at direct and indirect interactions with nuclear receptors.
Karaś K; Sałkowska A; Dastych J; Bachorz RA; Ratajewski M
Biomed Pharmacother; 2020 Jul; 127():110106. PubMed ID: 32248001
[TBL] [Abstract][Full Text] [Related]
25. Cardiac Glycosides as Immune System Modulators.
Škubník J; Pavlíčková V; Rimpelová S
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33947098
[TBL] [Abstract][Full Text] [Related]
26. Modulatory properties of cardiac and quercetin glycosides from Dacryodes edulis seeds during L-NAME-induced vascular perturbation.
Amadi PU; Agomuo EN; Adumekwe CW
J Basic Clin Physiol Pharmacol; 2020 Jul; 31(5):. PubMed ID: 32653874
[TBL] [Abstract][Full Text] [Related]
27. Evaluating the cancer therapeutic potential of cardiac glycosides.
Calderón-Montaño JM; Burgos-Morón E; Orta ML; Maldonado-Navas D; García-Domínguez I; López-Lázaro M
Biomed Res Int; 2014; 2014():794930. PubMed ID: 24895612
[TBL] [Abstract][Full Text] [Related]
28. Biochemical and cross-resistance studies with HeLa cell mutants resistant to cardiac glycoside SC4453. Regulation of the resistant form of Na+/K+-ATPase in the mutant cells.
Chopra A; Gupta RS
J Biol Chem; 1986 Feb; 261(5):2034-40. PubMed ID: 3003091
[TBL] [Abstract][Full Text] [Related]
29. Physiological role of the alpha1- and alpha2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site.
Dostanic-Larson I; Lorenz JN; Van Huysse JW; Neumann JC; Moseley AE; Lingrel JB
Am J Physiol Regul Integr Comp Physiol; 2006 Mar; 290(3):R524-8. PubMed ID: 16467499
[TBL] [Abstract][Full Text] [Related]
30. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.
Schoner W; Scheiner-Bobis G
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630
[TBL] [Abstract][Full Text] [Related]
31.
Bejček J; Jurášek M; Spiwok V; Rimpelová S
Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34064873
[TBL] [Abstract][Full Text] [Related]
32. Na
Bejček J; Spiwok V; Kmoníčková E; Rimpelová S
Molecules; 2021 Mar; 26(7):. PubMed ID: 33800655
[TBL] [Abstract][Full Text] [Related]
33. Cardiac Glycosides as Autophagy Modulators.
Škubník J; Svobodová Pavlíčková V; Psotová J; Rimpelová S
Cells; 2021 Nov; 10(12):. PubMed ID: 34943848
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
